But it will be up to doctors whether to use the combo in Darzalex-exposed patients.
ApexOnco Front Page
Recent articles
Persevera is a bust, but Roche hasn’t given up on the front line.
The CD70-targeting CTX131 heads for the scrapheap.
After more discontinuations, a new deal brings in fresh blood.
Bezuclastinib plus Sutent could become standard of care in second-line GIST.
Harmoni-A hits, backing a quiet disclosure about the Harmoni trial.
Inhibrx reveals three deaths in phase 1, but all predate screening protocols.
BG-75202 features among several projects starting first-in-human trials.
